Quantum BioPharma Ratios and Metrics

Market cap in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2020
Period Ending	Aug '25 Aug 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2020
Market Capitalization	141	10	47	40	53	38	Upgrade
Market Cap Growth	780.08%	-78.80%	18.00%	-24.98%	39.98%	-31.53%	Upgrade
Enterprise Value	140	0	42	8	4	21	Upgrade
Last Close Price	36.95	5.20	78.00	67.60	85.80	129.35	Upgrade
PB Ratio	50.50	0.67	2.77	0.97	0.78	0.82	Upgrade
P/TBV Ratio	-	1.06	4.54	1.60	1.11	1.31	Upgrade
Debt / Equity Ratio	1.11	0.08	0.03	0.02	0.01	0.01	Upgrade
Quick Ratio	0.36	1.65	2.39	2.22	4.13	3.17	Upgrade
Current Ratio	0.78	1.81	2.43	2.28	5.28	4.82	Upgrade
Return on Equity (ROE)	-456.81%	-127.76%	-83.91%	-63.08%	-75.05%	-78.40%	Upgrade
Return on Assets (ROA)	-76.42%	-58.31%	-43.02%	-33.82%	-40.20%	-43.79%	Upgrade
Return on Capital (ROIC)	-154.18%	-82.28%	-54.26%	-39.99%	-46.10%	-49.95%	Upgrade
Earnings Yield	-26.13%	-203.95%	-50.03%	-79.79%	-83.66%	-106.26%	Upgrade
FCF Yield	-	-98.75%	-30.26%	-96.15%	-49.19%	-63.93%	Upgrade
Buyback Yield / Dilution	85.58%	-86.67%	-2.21%	-10.84%	-190.15%	-70.69%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.